An Update on Flow Cytometry Analysis of Hematological Malignancies: Focus on Standardization
Open Access
Abstract
Flow cytometry use has significantly increased in clinical laboratories and has significantly helped improve the diagnosis of leukemias, lymphomas, and follow-up of minimal residual disease. Mastering this technique enables the performance of multiparametric single-cell analysis and increases the odds of identifying abnormal populations. As in many fields, there is a need to improve the quality of the data generated for accuracy, reproducibility, and trueness. The implementation of solutions reducing variability is achievable and needed, as the flow cytometry workflow involves many manual steps and items susceptible to operator bias and human error. Standardization of flow cytometry assays is sought and already implemented in many clinical hematology laboratories. However, the clinical community would highly benefit from further efforts in that direction to increase the comparability of findings across laboratories. This review covers the strengths and weaknesses of flow cytometry and focuses on the standardization approaches developed, including recent advances in the field.Keywords
This publication has 118 references indexed in Scilit:
- Novel Flow Cytometric Antibody Panel and Dedicated Analysis Algorithm for Automated Fully Standardized Minimal Residual Disease Detection in Chronic Lymphocytic LeukemiaAmerican Journal of Hematology, 2025
- Soluble B‐cell maturation antigen in multiple myelomaAmerican Journal of Hematology, 2024
- Cyt‐Geist: Current and Future Challenges in Cytometry: Reports of the CYTO 2019 Conference WorkshopsCytometry Part A, 2019
- Reproducibility of Flow Cytometry Through Standardization: Opportunities and ChallengesCytometry Part A, 2019
- Standardization, Calibration, and Control in Flow CytometryCurrent Protocols in Cytometry, 2017
- A flow cytometer for the measurement of Raman spectraCytometry Part A, 2008
- Interactions between mouse IgG2 antibodies are common and mediated by plasma C1qCytometry Part B: Clinical Cytometry, 2006
- U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory proceduresCytometry, 1997
- Clinical application of flow cytometry: A reviewCytometry, 1981
- Childhood CML in blastic stage: An analysis of cell markers and cell kineticsAmerican Journal of Hematology, 1980